0001209191-23-059179.txt : 20231219 0001209191-23-059179.hdr.sgml : 20231219 20231219164301 ACCESSION NUMBER: 0001209191-23-059179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231218 FILED AS OF DATE: 20231219 DATE AS OF CHANGE: 20231219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heery Christopher CENTRAL INDEX KEY: 0001789632 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41259 FILM NUMBER: 231497977 MAIL ADDRESS: STREET 1: C/O PRECISION BIOSCIENCES, INC. STREET 2: 302 E. PETTIGREW STREET, SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcellx, Inc. CENTRAL INDEX KEY: 0001786205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472855917 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25 WEST WATKINS MILL ROAD STREET 2: SUITE A CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-723-6641 MAIL ADDRESS: STREET 1: 25 WEST WATKINS MILL ROAD STREET 2: SUITE A CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-18 0 0001786205 Arcellx, Inc. ACLX 0001789632 Heery Christopher C/O ARCELLX, INC. 25 WEST WATKINS MILL ROAD, SUITE A GAITHERSBURG MD 20878 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-12-18 4 M 0 120000 6.28 A 127795 D Common Stock 2023-12-18 4 S 0 106912 50.0576 D 20883 D Common Stock 2023-12-18 4 S 0 12243 51.0251 D 8640 D Common Stock 2023-12-18 4 S 0 845 51.8612 D 7795 D Stock Option (right to buy) 6.28 2023-12-18 4 M 0 120000 0.00 D 2031-06-09 Common Stock 120000 120623 D Represents the weighted average share price of an aggregate total of 106,912 shares sold in the price range of $49.69 to $50.685 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 12,243 shares sold in the price range of $50.69 to $51.66 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 845 shares sold in the price range of $51.69 to $52.02 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Shares issued pursuant to the Issuer's 2017 Equity Incentive Plan (the "2017 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2017 Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 26, 2021. /s/ Rami Elghandour, as Attorney-in-Fact 2023-12-19